Presentation CHIP Washington DC 2017 Hybrid CTO: Where Are We and Where Are We Going Presenter: William Lombardi March 16, 2017 REGISTER for free or LOG IN to view this content Coronary CTO Presentation CHIP Washington DC 2017 Up Next Presentation CHIP Washington DC 2017 Hybrid CTO Case Review: Forwards, Backwards, True, Sub, or All of the Above? Presenter: Farouc Jaffer March 16, 2017 More slides + Presentation ACC 2017 A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Presenter: Magnus Ohman March 27, 2017 Presentation Miami Valves 2017 TAVR Year in Review: The Good the Bad and Ugly Presenter: Eduardo de Marchena January 29, 2017 We Recommend
Presentation CHIP Washington DC 2017 Hybrid CTO Case Review: Forwards, Backwards, True, Sub, or All of the Above? Presenter: Farouc Jaffer March 16, 2017
Presentation ACC 2017 A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Presenter: Magnus Ohman March 27, 2017
Presentation Miami Valves 2017 TAVR Year in Review: The Good the Bad and Ugly Presenter: Eduardo de Marchena January 29, 2017